Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001227964 | SCV001400345 | uncertain significance | Senior-Loken syndrome 7; Bardet-Biedl syndrome 16 | 2022-07-11 | criteria provided, single submitter | clinical testing | This sequence change replaces glycine, which is neutral and non-polar, with aspartic acid, which is acidic and polar, at codon 281 of the SDCCAG8 protein (p.Gly281Asp). This variant is present in population databases (rs765751496, gnomAD 0.003%). This variant has not been reported in the literature in individuals affected with SDCCAG8-related conditions. ClinVar contains an entry for this variant (Variation ID: 955345). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Fulgent Genetics, |
RCV001227964 | SCV002815948 | uncertain significance | Senior-Loken syndrome 7; Bardet-Biedl syndrome 16 | 2024-04-20 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004734059 | SCV005356540 | uncertain significance | SDCCAG8-related disorder | 2024-03-29 | no assertion criteria provided | clinical testing | The SDCCAG8 c.842G>A variant is predicted to result in the amino acid substitution p.Gly281Asp. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0029% of alleles in individuals of Latino descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |